Skip to main content

Table 1 Preoperative RT III clinical trials

From: Progress of preoperative and postoperative radiotherapy in gastric cancer

Study/institute

n

Tumor location

Groups

Local control

Survival

1998

Zhang et al. [6]

370

EGJ

RT+S vs. S

Local control and local recurrence rate 61.4% vs. 51.7%

10-year OS

20.3% vs. 13.3%

2009

Stahl et al. [7]

119

EGJ

CRT+S vs. C+S

Pathological complete response rate 15.6% vs. 2.0%

3-year OS

47.4% vs. 27.7%

2012

Van Hagen et al. [8]

366

EGJ or EC

CRT+S vs. S

Local recurrence rate 14% and 34%

5-year OS

47% vs. 34%

2002

Skoropad et al. [9]

102

GC

RT+S vs. S

No sense

No sense

  1. EGJ esophagogastric junction, GC gastric cancer, EC esophagus cancer, RT radiotherapy, CRT concurrent radiotherapy, S surgery